CN Patent

CN107488194B — 一种阿法替尼中间体及其制备方法

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2021-07-30 · 5y expired

What this patent protects

本发明揭示了一种新颖阿法替尼的中间体Ⅲ及其制备方法，包括如下步骤：N‑(3‑氯‑4‑氟苯基)‑7‑氟‑6‑硝基‑4‑喹唑啉胺还原得N‑(3‑氯‑4‑氟苯基)‑7‑氟‑6‑氨基‑4‑喹唑啉胺Ⅳ，再与二乙磷乙酸发生缩合反应得Ⅲ。本发明方法收率高、纯度高。

USPTO Abstract

本发明揭示了一种新颖阿法替尼的中间体Ⅲ及其制备方法，包括如下步骤：N‑(3‑氯‑4‑氟苯基)‑7‑氟‑6‑硝基‑4‑喹唑啉胺还原得N‑(3‑氯‑4‑氟苯基)‑7‑氟‑6‑氨基‑4‑喹唑啉胺Ⅳ，再与二乙磷乙酸发生缩合反应得Ⅲ。本发明方法收率高、纯度高。

Drugs covered by this patent

Patent Metadata

Patent number
CN107488194B
Jurisdiction
CN
Classification
—
Expires
2021-07-30
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.